# Bupivacaine Injection of Eye Muscles to Treat Strabismus

> **NCT01616108** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Smith-Kettlewell Eye Research Institute** · enrollment: 120 (estimated)

## Conditions studied

- Strabismus
- Esotropia
- Exotropia
- Graves Disease
- Ptosis, Eyelid

## Interventions

- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT01616108
- **Lead sponsor:** Smith-Kettlewell Eye Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2019-09
- **Final completion:** 2020-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-09-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01616108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01616108, "Bupivacaine Injection of Eye Muscles to Treat Strabismus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01616108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*